| AVANTOR-FUNDING-INC |
AVANTOR-FUNDING-INC |
62%
|
ng table presents a summary of cash provided by (used in) various activities: (in millions) Year ended December 31, Change 2025 2024 Operating activities: Net (loss) income $ (530.2) $ 711.5 $ (1,241… |
| DELAWARE-GENERAL-CORPORATION |
DELAWARE-GENERAL-CORPORATION |
62%
|
or retaining business, and we operate in many parts of the world that have experienced corruption to some degree. Any such improper actions or allegations of such acts could damage our reputation and… |
| F-10-AVANTOR-INC |
F-10-AVANTOR-INC |
62%
|
ows from financing activities: Debt borrowings $ 1,107.6 $ — $ — Debt repayments ( 1,426.3 ) ( 1,341.8 ) ( 846.0 ) Payments of debt refinancing fees ( 15.1 ) — ( 2.3 ) Proceeds received from exercise… |
| HEALTH-ADMINISTRATION-RITTER-RITTER-GMBH |
HEALTH-ADMINISTRATION-RITTER-RITTER-GMBH |
62%
|
eriod other than Short-Term Masterflex Masterflex LLC, a company we acquired in November 2021 NAV Net Asset Value NIH National Institutes of Health NuSil NuSil Acquisition Corp, NuSil Investments LLC… |
| HEALTH-NUSIL-NUSIL-ACQUISITION-CORP-NUSIL-INVEST |
HEALTH-NUSIL-NUSIL-ACQUISITION-CORP-NUSIL-INVEST |
62%
|
eriod other than Short-Term Masterflex Masterflex LLC, a company we acquired in November 2021 NAV Net Asset Value NIH National Institutes of Health NuSil NuSil Acquisition Corp, NuSil Investments LLC… |
| J-T-BAKER-CHEMICAL-COMPANY |
J-T-BAKER-CHEMICAL-COMPANY |
62%
|
n in 1904 with the founding of the J.T. Baker Chemical Company. In 2010, we were acquired by New Mountain Capital from Covidien plc. Since then, we have expanded through a series of large acquisition… |
| MALLINCKRODT-BAKER-INC |
MALLINCKRODT-BAKER-INC |
62%
|
.4 20.4 823.8 Ending balance, gross $ 3,892.7 $ 1,918.0 $ 5,810.7 (in millions) December 31, 2024 Laboratory Solutions Bioscience Production Total Beginning balance, net $ 3,823.6 $ 1,893.1 $ 5,716.7… |
| MALLINCKRODT-GROUP |
MALLINCKRODT-GROUP |
62%
|
.4 20.4 823.8 Ending balance, gross $ 3,892.7 $ 1,918.0 $ 5,810.7 (in millions) December 31, 2024 Laboratory Solutions Bioscience Production Total Beginning balance, net $ 3,823.6 $ 1,893.1 $ 5,716.7… |
| SHORT-TERM-MASTERFLEX-MASTERFLEX-LLC |
SHORT-TERM-MASTERFLEX-MASTERFLEX-LLC |
62%
|
eriod other than Short-Term Masterflex Masterflex LLC, a company we acquired in November 2021 NAV Net Asset Value NIH National Institutes of Health NuSil NuSil Acquisition Corp, NuSil Investments LLC… |
| VWR-VWR-CORPORATION |
VWR-VWR-CORPORATION |
62%
|
eriod other than Short-Term Masterflex Masterflex LLC, a company we acquired in November 2021 NAV Net Asset Value NIH National Institutes of Health NuSil NuSil Acquisition Corp, NuSil Investments LLC… |